SOD1 and amyotrophic lateral sclerosis: In the ALS transgenic rat model, the chronic intraspinal infusion of exogenous unmutated human SOD1 significantly delayed disease progression, suggesting a novel extracellular role for SOD1 in ALS pathogenesis and therapy [16].